# Hangzhou Just Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-just-biotherapeutics

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Website: www.justbiochina.com
- Total disclosed funding: $95M
- Latest round: Series B (Jun 6, 2018)
- Investors on record: 10

## About

Founded in 2015 and based in Hangzhou, China, Hangzhou Just Biotherapeutics, Inc. operates as an integrated design company focused on the technologies that will improve the development of biotherapeutics.

## Funding rounds

- Series B, Jun 6, 2018, $35M — ARCH Venture Partners, Temasek Holdings, Taikang Asset Management, Lilly Asia Ventures, BOCGI Zheshang Capital, Hillhouse Investment
- Series B, Aug 8, 2017, $60M — ARCH Venture Partners, Temasek Holdings, Lilly Asia Ventures, Bank Of China, Taikang Life, Bank Of Hangzhou, Hangzhou Economic and Technological Development Area

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B
- Temasek Holdings — Series B
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series B
- Bank Of China — Series B
- Taikang Life — Series B
- Bank Of Hangzhou — Series B
- Hangzhou Economic and Technological Development Area — Series B
- Taikang Asset Management — Series B
- BOCGI Zheshang Capital (https://capitalatlas.ai/funds/bocgi-zheshang-capital) — Series B
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series B